Reuters logo
BRIEF-Idogen: European Patent Office intends to grant Idogen's patent application
January 13, 2017 / 2:33 PM / 8 months ago

BRIEF-Idogen: European Patent Office intends to grant Idogen's patent application

Jan 13 (Reuters) - Idogen AB :

* Says the European Patent Office (EPO) has issued a “Notice of Intention to Grant”, which means that the patent office intends to grant Idogen’s patent application, covering the company’s tolerogenic vaccine technology

* The patent, and its validation in key European countries, will provide Idogen’s tolerogenic vaccine technology with broad protection and further strengthens the company’s patent portfolio

Source text: bit.ly/2jeVL5x

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below